Format

Send to

Choose Destination
Nat Rev Cancer. 2013 Mar;13(3):172-83. doi: 10.1038/nrc3461. Epub 2013 Feb 7.

Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics.

Author information

1
IRB-Barcelona, c/Baldiri Reixac 10-12, Barcelona, Spain. gonzalez@ irbbarcelona.org

Abstract

For decades, lower-model organisms such as Drosophila melanogaster have often provided the first glimpse into the mechanism of action of human cancer-related proteins, thus making a substantial contribution to elucidating the molecular basis of the disease. More recently, D. melanogaster strains that are engineered to recapitulate key aspects of specific types of human cancer have been paving the way for the future role of this 'workhorse' of biomedical research, helping to further investigate the process of malignancy, and serving as platforms for therapeutic drug discovery.

PMID:
23388617
DOI:
10.1038/nrc3461
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center